Abbott's MDx Sales Jump 19 Percent in Q2

The firm's molecular diagnostics sales increased to $105 million for the quarter from $89 million in Q2 2010.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories